These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 31482072)

  • 1. Evolutionary and Structural Overview of Human Picornavirus Capsid Antibody Evasion.
    Cifuente JO; Moratorio G
    Front Cell Infect Microbiol; 2019; 9():283. PubMed ID: 31482072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-like particles in picornavirus vaccine development.
    Dong H; Guo HC; Sun SQ
    Appl Microbiol Biotechnol; 2014 May; 98(10):4321-9. PubMed ID: 24647496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immune evasion by picornaviruses.
    Zhang X; Paget M; Wang C; Zhu Z; Zheng H
    Eur J Immunol; 2020 Sep; 50(9):1268-1282. PubMed ID: 32767562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of virus-like particles and nanoparticle-based vaccines for combating picornavirus infections.
    Ren M; Abdullah SW; Pei C; Guo H; Sun S
    Vet Res; 2024 Sep; 55(1):128. PubMed ID: 39350170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring Canine Picornavirus Diversity in the USA Using Wastewater Surveillance: From High-Throughput Genomic Sequencing to Immuno-Informatics and Capsid Structure Modeling.
    Faleye TOC; Skidmore P; Elyaderani A; Adhikari S; Kaiser N; Smith A; Yanez A; Perleberg T; Driver EM; Halden RU; Varsani A; Scotch M
    Viruses; 2024 Jul; 16(8):. PubMed ID: 39205161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Globally defining the effects of mutations in a picornavirus capsid.
    Mattenberger F; Latorre V; Tirosh O; Stern A; Geller R
    Elife; 2021 Jan; 10():. PubMed ID: 33432927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human picornaviruses associated with neurological diseases and their neutralization by antibodies.
    Anastasina M; Domanska A; Palm K; Butcher S
    J Gen Virol; 2017 Jun; 98(6):1145-1158. PubMed ID: 28631594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of human rhinovirus immunogenic epitopes for rational vaccine design.
    Stepanova E; Isakova-Sivak I; Rudenko L
    Expert Rev Vaccines; 2019 Sep; 18(9):877-880. PubMed ID: 31416365
    [No Abstract]   [Full Text] [Related]  

  • 9. Parvovirus Capsid Structures Required for Infection: Mutations Controlling Receptor Recognition and Protease Cleavages.
    Callaway HM; Feng KH; Lee DW; Allison AB; Pinard M; McKenna R; Agbandje-McKenna M; Hafenstein S; Parrish CR
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The conserved N-terminus of human rhinovirus capsid protein VP4 contains membrane pore-forming activity and is a target for neutralizing antibodies.
    Panjwani A; Asfor AS; Tuthill TJ
    J Gen Virol; 2016 Dec; 97(12):3238-3242. PubMed ID: 27902347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction and suppression of innate antiviral responses by picornaviruses.
    Feng Q; Langereis MA; van Kuppeveld FJ
    Cytokine Growth Factor Rev; 2014 Oct; 25(5):577-85. PubMed ID: 25086453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Picornaviruses and Apoptosis: Subversion of Cell Death.
    Croft SN; Walker EJ; Ghildyal R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic Vascular Endothelial Growth Factor-Blocking Peptides Displayed on the Capsid of an Infectious Oncolytic Parvovirus: Assembly and Immune Interactions.
    Grueso E; Sánchez-Martínez C; Calvo-López T; de Miguel FJ; Blanco-Menéndez N; Fernandez-Estevez M; Elizalde M; Sanchez J; Kourani O; Martin D; Tato A; Guerra M; Andrés G; Almendral JM
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31315994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Picornavirus subversion of the autophagy pathway.
    Klein KA; Jackson WT
    Viruses; 2011 Sep; 3(9):1549-61. PubMed ID: 21994795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Picornavirus and enterovirus diversity with associated human diseases.
    Tapparel C; Siegrist F; Petty TJ; Kaiser L
    Infect Genet Evol; 2013 Mar; 14():282-93. PubMed ID: 23201849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral and host proteins involved in picornavirus life cycle.
    Lin JY; Chen TC; Weng KF; Chang SC; Chen LL; Shih SR
    J Biomed Sci; 2009 Nov; 16(1):103. PubMed ID: 19925687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chickens host diverse picornaviruses originated from potential interspecies transmission with recombination.
    Lau SKP; Woo PCY; Yip CCY; Li KSM; Fan RYY; Bai R; Huang Y; Chan KH; Yuen KY
    J Gen Virol; 2014 Sep; 95(Pt 9):1929-1944. PubMed ID: 24906980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avian picornaviruses: molecular evolution, genome diversity and unusual genome features of a rapidly expanding group of viruses in birds.
    Boros Á; Pankovics P; Reuter G
    Infect Genet Evol; 2014 Dec; 28():151-66. PubMed ID: 25278047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a short, highly conserved, motif required for picornavirus capsid precursor processing at distal sites.
    Kristensen T; Belsham GJ
    PLoS Pathog; 2019 Jan; 15(1):e1007509. PubMed ID: 30657784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Basis for Escape of Human Astrovirus from Antibody Neutralization: Broad Implications for Rational Vaccine Design.
    Bogdanoff WA; Perez EI; López T; Arias CF; DuBois RM
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29070688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.